Use of Higher Dosage Strength Oral and Transmucosal Opioid Analgesics

Basic Details
Date Posted
Wednesday, July 31, 2019
Medical Product
higher dosage strength opioid analgesic
lower dosage strength opioid analgesic
opioid analgesic
oral opioid analgesic
transdermal opioid analgesic
transmucosal opioid analgesic

This analysis consists of two reports. Report 1 estimates background rates of higher dosage strength opioid analgesic users in the Sentinel Distributed Database (SDD). Report 2 calculates summary statistics on length of treatment episode among users of higher dosage strength opioid analgesics in the SDD. Data from January 1, 2012 to June 30, 2018 from 17 Data Partners contributing to the SDD were included in this request. This request was distributed to Data Partners on November 12, 2018.

Additional Details
FDA Center
Time Period
January 1, 2012 - June 30, 2018
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)